How Zyn helped Philip Morris International make a comeback
Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...
business-review.eu2d
Philip Morris International announces that the U.S. Food and Drug Administration have authorized the marketing of ZYN Nicotine Pouch Products
The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...
Scientific American6d
What’s in ZYN, the FDA-Authorized Nicotine Pouch? Is It Harmful?
ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some ...
Business Wire12h
Philip Morris International to Host Webcast of 2024 Fourth-Quarter and Full-Year Results
Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a ...
British American Tobacco, Altria shares rise after menthol ban proposal dropped
The news is particularly relevant for British American Tobacco, which, along with its industry peers, can now potentially ...
4 Soaring Stocks I'd Buy Now With No Hesitation
While technology stocks get a lot of attention from the media, there are a lot of attractive options in the consumer goods ...
Barclays Sticks to Their Buy Rating for Philip Morris (PM)
Barclays analyst Gaurav Jain maintained a Buy rating on Philip Morris (PM – Research Report) today and set a price target of $145.00. The ...
Rolling Out1d
Why the FDA says menthol cigarettes must go now
The Food and Drug Administration has ignited a heated debate with its latest review of menthol cigarettes, revealing ...
Philip Morris Positioned for Growth Amid Attractive Valuation and Market Opportunities
Philip Morris (PM) has received a new Buy rating, initiated by Morgan Stanley analyst, Eric Serotta.Invest with Confidence: Follow TipRanks' ...